Wendy Johnson

Wendy Johnson

Corporate Officer/Principal bij RENEO PHARMACEUTICALS, INC.

Vermogen: 1 950 $ op 31-05-2024

72 jaar
Health Technology
Consumer Services
Finance

Profiel

Wendy S.
Johnson
founded Palkion, Inc. in 2008, where she worked as President and Aires Pharmaceuticals, Inc. in 2006, where she worked as President & Chief Executive Officer from 2006 to 2014.
Ms. Johnson also currently works at Gemini Advisors, as Managing Director, Accelerator Services Corp, as Operating Partner, Reneo Pharmaceuticals, Inc., as Chief Business Officer from 2021, and Formation Bio Inc, as Advisor.
Ms. Johnson also formerly worked at AmpliPhi Biosciences Corp., as Director from 2017 to 2019, US Food & Drug Administration, as Assistant Director-Devices & Radiological Health, Center for Devices & Radiological Health, as Assistant Director from 1976 to 1986, Exagen, Inc., as Independent Director from 2020 to 2024, Synbiotics LLC, as Manager-Business Development from 1988 to 1990, Women First HealthCare, Inc., as Vice President-Business Development from 1998 to 2000, ProQuest Management LLC, as Venture Partner from 2005 to 2014, Salmedix, Inc., as Senior Vice President-Corporate Development from 2001 to 2004, MorphoSys AG, as Member-Supervisory Board from 2015 to 2022, Prizm Pharmaceuticals, Inc., as Principal, Mutual of New York Life, as Vice President, Selective Genetics, Inc., as Vice President-Corporate Development & Operations from 1994 to 1998, Murex Corp., as Manager-International Business Development from 1988 to 1990, and Cytel Corp., as VP-Business Development & Regulatory Affairs from 1990 to 1994.
Ms. Johnson received her Masters Business Admin degree in 1986 from Loyola Marymount University, undergraduate degree in 1974 from the University of Maryland, and graduate degree from Drexel University College of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-04-2024 1 000 ( 0.01% ) 1 950 $ 31-05-2024

Actieve functies van Wendy Johnson

BedrijvenFunctieBegin
RENEO PHARMACEUTICALS, INC. Corporate Officer/Principal 01-01-2021
Consultant / Adviseur -
Algemeen Directeur -
Private Equity Investor -
Alle actieve functies van Wendy Johnson

Eerdere bekende functies van Wendy Johnson

BedrijvenFunctieEinde
EXAGEN INC. Directeur/Bestuurslid 10-06-2024
MORPHOSYS AG Directeur/Bestuurslid 18-05-2022
Operationeel Directeur 30-01-2017
Private Equity Investor 30-03-2014
Algemeen Directeur 01-03-2014
Ervaring van Wendy Johnson in detail bekijken

Opleiding van Wendy Johnson

Loyola Marymount University Masters Business Admin
University of Maryland Undergraduate Degree
Drexel University College of Medicine Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Wendy Johnson in detail bekijken

Connecties

100 +

Eerstegraads connecties

23

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
MORPHOSYS AG

Health Technology

EXAGEN INC.

Health Services

RENEO PHARMACEUTICALS, INC.

Health Technology

Bedrijven in privébezit17

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Prizm Pharmaceuticals, Inc.

Health Technology

Mutual of New York Life /2 Hampton Inns/

Consumer Services

Health Technology

Government

Murex Corp.

Finance

Health Services

Cytel Corp.

Center for Devices & Radiological Health

Government

Commercial Services

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Wendy Johnson